Showing results (421-430 of 979) with videos related to
Sort By:
Pageof 98
Current Drug Safety|September 25, 2021
Skin Tests for the Exploration of Hypersensitivity Reactions Associated with Iodinated Contrast MediaAhmed Zaiem, Syrine Ben Hammamia, Fares Ben Salem, et al.Current Drug Safety|April 6, 2022
The Sustainability of the Impact of Pharmacists' Educational Programs on the Adherence to the Recommendations of Preoperative Antibiotic Prophylaxis GuidelinesMaryam Rangchian, Tina Shah-Ebrahimi, Maryam MehrpooyaCurrent Drug Safety|April 6, 2022
Coronavirus Disease 2019 and Hypertension: How Anti-hypertensive Drugs Affect COVID-19 Medications and Vice VersaAida Doostkam, Alireza Hosseinpour, Kamyar Iravani, et al.Current Drug Safety|May 17, 2023
Methotrexate-induced Severe Pancytopenia in a Patient with Rheumatoid Arthritis: A Case Report and Review of LiteratureElham Hosseini, Foroud ShahbaziCurrent Drug Safety|May 3, 2023
Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of IndiaShalini Shukla, Priyanka Sharma, Priya Gupta, et al.Current Drug Safety|August 21, 2020
Sodium Glucose Cotransporter-2 Inhibitor Treatment and the Risk of Diabetic Ketoacidosis in Denmark: A Retrospective Cohort Study of Five Years of UseHenrik V B Laursen, Johan B Røikjer, Jakob Dal, et al.Current Drug Safety|August 22, 2020
Efficacy and Cardiovascular Safety of DPP-4 InhibitorsNikhila A Subrahmanyan, Rithika M Koshy, Koshy Jacob, et al.Current Drug Safety|August 26, 2020
Impact of Climatic Variations on Drug-induced Skin Reactions in Two Different Regions of IndiaTirthankar Deb, Abhishek Ghosh, Chanchal Kumar Dalai, et al.Current Drug Safety|October 16, 2012
MIA-QSAR modeling of the anti-HIV-1 protease activities and cytotoxicities of ritonavir analogsDaniel G Silva, Matheus P FreitasCurrent Drug Safety|October 16, 2012
QSAR study for carcinogenicity in a large set of organic compoundsPablo R Duchowicz, Nieves C Comelli, Erlinda V Ortiz, et al.Pageof 98